Loading startup
Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.
Evidence-bound summary — expand sections for movement, risks, and signals.
Memo snapshot · May 20, 2026, 6:02 PM
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
TL;DR
Seed (YC)Panoptive | Decision Infrastructure for Clinical Trial Oversight Run and defend clinical trial oversight
Stage: Seed (YC) — specific raise amount not disclosed in indexed public sources.
Funding
MediumStage: Seed (YC) — specific raise amount not disclosed in indexed public sources.
Hiring
1 hiring‑related row(s); role‑spam risk if mostly generic boards (Low).
Product / news
1 product/news‑styled row(s); headline risk without filings (High).
Verified facts
YC S25 company: oversight engine for clinical trials.
Weak funding evidence: mention does not include a parsed raise amount/round and may refer to non-funding context.
No open roles indexed yet.
The index price and activity score are algorithmic estimates based on observed public company-level signals. They may be incomplete, stale, or inaccurate and are not investment, legal, tax, or business advice.
Source types found
Strongest / recent news-style rows
Wed, May 20, 06:02 PM · confidence 85%high quality
Wed, May 20, 06:02 PM · confidence 85%high quality
wikipedia · Mon, Jun 29, 01:07 AM · confidence 50%low quality
Newest first · 7 event(s)
Source: Careers page
Join Panoptive and help build the future of clinical trial oversight. View open positions in engineering, product, sales, and customer success.
Source: Homepage
Run and defend clinical trial oversight. Turn monitoring reports and EDC data into structured findings, documented decisions, and a continuously audit-ready oversight record.
Founding engineer roles and company hiring.
Official product site for clinical trial oversight platform.
YC S25 company: oversight engine for clinical trials.
2 row(s)
The company's own site — the authoritative description of what they sell and to whom. Marketing-controlled, so treat claims as positioning rather than verified traction.
Run and defend clinical trial oversight. Turn monitoring reports and EDC data into structured findings, documented decisions, and a continuously audit-ready oversight record.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Official product site for clinical trial oversight platform.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗3 row(s)
Third-party press coverage. Independent reporting corroborates company claims; repeated coverage across outlets is a momentum signal.
Founding engineer roles and company hiring.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗1 row(s)
Funding announcements and investor-database records. The strongest public signal of capitalization: round, amount, and syndicate quality when disclosed.
YC S25 company: oversight engine for clinical trials.
Why it matters: Funding signal — capitalization evidence; check the linked source for round, amount, and investors.
Open source ↗1 row(s)
Open roles and careers pages. Active hiring implies runway to spend and shows where the company is investing (engineering vs GTM vs ops).
Join Panoptive and help build the future of clinical trial oversight. View open positions in engineering, product, sales, and customer success.
Why it matters: Hiring signal — open roles imply runway to spend and show where the company is investing.
Open source ↗Sign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.